Add like
Add dislike
Add to saved papers

Gender-Based Comparison of Takotsubo Syndrome versus Patients with Myocardial Infarction.

Disclosures: There is no potential conflict of interest to disclose for any of the co-authors.

Objectives: Takotsubo Syndrome (TTS) is an acute reversible left ventricular (LV) dysfunction. Recently published studies have highlighted a similar mortality rate as acute coronary syndrome (ACS). We compared the impact of gender differences on the outcome of TTS patients as compared to ACS patient.

Material and methods: We included a collective of 138 patients TTS between 2003 and 2016 at our institution. Patients were divided according to their gender into two groups (Males n = 21, 15% and females, n = 117, 85%). They were compared with a cohort of 300 patients with a diagnosis of ACS.

Results: On the acute phase, in male patients with TTS, a treatment with inotropic was more often required (33.3% vs. 11.5%, p < 0.01), were more susceptible to cardiogenic shock (28.6% vs. 12.5%, p < 0.04). Concerning the long term prognosis after the acute event, male patients had higher all-cause mortality over long-term follow-up. A Kaplan-Meier analysis indicated that the mortality of male patients with TTS was significantly higher compared to male patients with ACS (log-rank<0.01), while there was no significant difference between female patients with TTS and ACS (log-rank=0.60, p = 0.45). In a multivariate cox regression analysis, male gender (HR 2.7, 95% CI: 1.1-6.5, p = 0.02) GFR<60 ml/min. (HR 2.8, 95% CI: 1.2-6.0, p = 0.01) and history of cancer (HR 3.6, 95% CI 1.4-9.3, p < 0.01) were independent predictors of 5 year mortality.

Conclusions: Considerable evidence suggests that TTS compared to ACS implicates more significant clinical short-term events on male patients and it may be associated with poorer long-term prognosis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app